You are on page 1of 1

Federal Register / Vol. 70, No.

133 / Wednesday, July 13, 2005 / Notices 40387

Dated: July 5, 2005. DEPARTMENT OF HEALTH AND amended (5 U.S.C. Appendix 2), notice
LaVerne Y. Stringfield, HUMAN SERVICES is hereby given of the following
Director, Office of Federal Advisory meetings.
Committee Policy. National Institutes of Health The meetings will be closed to the
[FR Doc. 05–13813 Filed 7–12–05; 8:45 am] public in accordance with the
National Cancer Institute; Notice of provisions set forth in sections 552(c)(4)
BILLING CODE 4140–01–M Closed Meeting and 552b(c)(6), Title 5 U.S.C., as
Pursuant to section 10(d) of the amended. the grant applications and the
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as discussions could disclose confidential
HUMAN SERVICES amended (5 U.S.C. Appendix 2), notice trade secrets or commercial property
is hereby given of the following such as patentable material, and
National Institutes of Health meeting. personal information concerning
The meeting will be closed to the individuals associated with the grant
National Cancer Institute; Notice of public in accordance with the applications, the disclosure of which
Closed Meeting provisions set forth in sections would constitute a clearly unwarranted
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy.
Pursuant to section 10(d) of the as amended. The grant applications and Name of Committee: National Center on
Federal Advisory Committee Act, as the discussions could disclose Minority Health and Health Disparities
amended (5 U.S.C. Appendix 2), notice confidential trade secrets or commercial Special Emphasis Panel, MCMHD
is hereby given of the following property such as patentable material, Community-Based Participatory Research &
meeting. and personal information concerning Outreach.
Date: July 18–20, 2005.
The meeting will be closed to the individuals associated with the grant
Time: 2 p.m. to 5 p.m.
public in accordance with the applications, the disclosure of which Agenda: To review and evaluate grant
provisions set forth in sections would constitute a clearly unwarranted applications.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy. Place: Embassy Suites at the Chevy Chase
as amended. The contract proposals and Name of Committee: National Cancer Pavilion, 4300 Military Road, NW.,
the discussions could disclose Institute Initial Review Group, Subcommittee Washington, DC 20015.
E—Cancer Epidemiology, Prevention & Contact Person: Merlyn M. Rodrigues, PhD,
confidential trade secrets or commercial MD, Director, Office of Extramural Activities,
property such as patentable material, Control.
Date: August 11–12, 2005. National Center On Minority Health, and
and personal information concerning Health Disparities, National Institute of
Time: 8 a.m. to 12 p.m.
individuals associated with the contract Agenda: To review and evaluate grant Health, 6707 Democracy Blvd. Suite 800,
proposals, the disclosure of which applications. Bethesda, MD 20894, (301) 402–1366,
would constitute a clearly unwarranted Place: Bethesda North Marriott, 5701 rodrigm1@mail.nih.gov.
invasion of personal privacy. Marinelli Road, North Bethesda, MD 20852. Name of Committee: National Center on
Contact Person: Mary C. Fletcher, PhD, Minority Health and Health Disparities
Name of Committee: National Cancer Special Emphasis Panel, Project EXPORT—
Scientific Review Administrator, Research
Institute Special Emphasis Panel, Lab Programs Review Branch, Division of Establishing Exploratory Centers.
Assessment of Tobacco Use Behavior & Extramural Activities, National Cancer Date: July 24–26, 2005.
Exposure Toxins. Institute, National Institutes of Health, 6116 Time: 5 p.m. to 2 p.m.
Date: August 4, 2005. Executive Boulevard, Rm 8115, Bethesda, Agenda: To review and evaluate grant
Time: 8 a.m. to 4 p.m. MD 20892, (301) 496–7413. applications.
Agenda: To review and evaluate contract (Catalogue of Federal Domestic Assistance Place: Embassy Suites at the Chevy Chase
proposals. Program Nos. 93.392, Cancer Construction; Pavilion, 4300 Military Road, NW.,
Place: Holiday Inn Select Bethesda, 8120 93.393, Cancer Cause and Prevention Washington, DC 20015.
Wisconsin Ave, Bethesda, MD 20814. Research; 93.394, Cancer Detection and Contact Person: Lorrita Watson, PhD,
Diagnosis Research; 93.395, Cancer National Center on Minority Health and
Contact Person: Joyce C. Pegues, PhD,
Treatment Research; 93.396, Cancer Biology Health Disparities, National Institutes of
Scientific Review Administrator, Special Health, 6707 Democracy Blvd., Suite 800,
Research; 93.397, Cancer Centers Support;
Review and Logistics Branch, Division of Bethesda, MD 20892–5465, 301–594–7784,
93.398, Cancer Research Manpower; 93.399,
Extramural Activities, National Cancer Cancer Control, National Institutes of Health, watsonl@ncmhd.nih.gov.
Institute, 6116 Executive Blvd. 7149, HHS) Dated: June 30, 2005.
Bethesda, MD 20892, 301/594–1286,
peguesj@mail.nih.gov. Dated: July 5, 2005. LaVerne Y. Stringfield,
LaVerne Y. Stringfield, Director, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance
Director, Office of Federal Advisory Committee Policy.
Program Nos. 93.392, Cancer Construction;
Committee Policy. [FR Doc. 05–13811 Filed 7–12–05; 8:45 am]
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and [FR Doc. 05–13817 Filed 7–12–05; 8:45 am] BILLING CODE 4140–01–M

Diagnosis Research; 93.395, Cancer BILLING CODE 4140–01–M


Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support; DEPARTMENT OF HEALTH AND
93.398, Cancer Research Manpower; 93.399, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Cancer Control, National Institutes of Health, HUMAN SERVICES
HHS)
National Institutes of Health
National Institutes of Health
Dated: July 5, 2005. National Eye Institute; Notice of Closed
LaVerne Y. Stringfield, National Center on Minority Health and Meeting
Director, Office of Federal Advisory Health Disparities; Notice of Closed
Pursuant to section 10(d) of the
Committee Policy. Meetings
Federal Advisory Committee Act, as
[FR Doc. 05–13816 Filed 7–12–05; 8:45 am] Pursuant to section10(d) of the amended (5 U.S.C. Appendix 2), notice
BILLING CODE 4140–01–M Federal Advisory Committee Act, as is hereby given of a meeting of the

VerDate jul<14>2003 17:40 Jul 12, 2005 Jkt 205001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\13JYN1.SGM 13JYN1

You might also like